Table 2.
Baseline Characteristics of Patients Included in the Studya
| Recently infected | Chronically infected | Total | |
|---|---|---|---|
| Participants, No. (%) | 17 (23.6) | 55 (76.4) | 72 (100.0) |
| Sex, No. (%) | |||
| Male | 16 (94.1) | 43 (78.2) | 59 (81.9) |
| Female | 1 (5.9) | 12 (21.8) | 13 (18.1) |
| Age, mean (SD) | 32.0 (5.8) | 40.0 (12.2)b | 38.1 (11.5) |
| Risk factor, No. (%) | |||
| Homosexual contact | 15 (88.2)c | 28 (50.9) | 43 (59.7) |
| Heterosexual contact | 1 (5.9)c | 19 (34.5) | 20 (27.8) |
| Intravenous drug user | 1 (5.9) | 3 (5.5) | 4 (5.6) |
| Other/unknown | 0 (0.0) | 5 (9.1) | 5 (6.9) |
| Coinfection, No. (%) | |||
| HBV | 1 (5.6) | 14 (20.9) | 15 (17.6) |
| HCV | 1 (5.6) | 9 (13.4) | 10 (11.8) |
| CD4+/μl, median (IQR) | 510 (354–719) | 333 (168–574)d | 395 (226–617) |
| HIV-RNA log10 copies/ml, median (IQR) | 4.6 (4.3–5.3) | 4.7 (4.1–5.1) | 4.6 (4.1–5.1) |
a
No, number; SD, standard deviation; IQR, interquartile range.
b
p < 0.05 compared to recently infected; Student's t test.
c
p < 0.05; chi-squared test.
d
p < 0.05 compared to recently infected; Mann–Whitney U test.